Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells

Oncogene

Volumn 18, Issue 6, 1999, Pages 1325-1332

  Tari, Ana Maria ^a   Hung, Mien Chie ^a   Li, Kaiyi ^a   Lopez Berestein, Gabriel ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Breast cancer; EGFR; ErbB2; Grb2; MAP kinase

Indexed keywords

ADAPTOR PROTEIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; LIPOSOME; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEU DIFFERENTIATION FACTOR; PROTEIN TYROSINE KINASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0033545371     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202422     Document Type: Article

References (65)

1. Akiyama T, Sudo C, Ogawara H, Toyoshima K and Yamamoto T. (1986). Science, 232, 1644-1646.
2. Alimandi M, Romano A and Curia M. (1995). Oncogene, 10, 1813-1821.
3. Bargmann C, Hung M-C and Weinberg R. (1986). Nature, 319, 226-234.
4. Baselga J, Norton L, Masui H, Coplan K, Miller Jr. W and Mendelsohn J. (1993). J. Natl. Can. Inst., 85, 1327-1333.
5. Batzer A, Rotin D, Urena J, Skolnik E and Schlessinger J. (1994). Mol. Cell. Biol, 14, 5192-5201.
6. Bonfini L, Karlovich C, Dasgupta C and Banerjee U. (1992). Science, 255, 603-606.
7. Bowtell D, Fu P, Simon M and Senior P. (1992). Proc. Natl. Acad. Sci. USA, 89, 6511-6515.
8. Buday L and Downward J. (1993a). Cell, 73, 611-620.
9. Buday L and Downward J. (1993b). Mol. Cell. Biol., 13, 1903-1910.
10. Cance W and Liu E. (1995). Breast Cancer Res. Treat., 35, 105-114.
11. Chrysogelos S and Dickson R. (1994). Breast Cancer Res. Treat., 29, 29-40.
12. Clark S, Stern M and Horvitz H. (1992). Nature, 356, 340-344.
13. Daly R, Binder M and Sutherland R. (1994). Oncogene, 9, 2723-2727.
14. Di Fiore P, Pierce J, Kraus M, Seqatto O, King C and Aaranson S. (1987). Science, 237, 178-182.
15. DiGiovanna M and Stern D. (1995). Cancer Res., 55, 1946-1955.
16. Downward J, Parker P and Waterfield M. (1984). Nature, 311, 483-485.
17. Duesbery N, Webb C, Leppla S, Gordon V, Klimpel K, Copeland T, Ahn N, Oskarsson M, Fukasawa K, Paull K and Van de Woude G. (1998). Science, 280, 734-737.
18. Ennis B, Valverius E, Lippman M, Bellot F, Kris R, Schlessinger J, Masui H, Goldenberg A and Mendelsohn J. (1989). Mol. Endocrinol., 3, 1830-1838.
19. Filmus J, Pollak M, Cailleau R and Buick R. (1985). Biochem. Biophys. Res. Comm., 128, 898-905.
20. Fitzpatrick S, LaChance M and Schultz G. (1984). Cancer Res., 44, 3442-3447.
21. Gardner A, Vaillancourt R and Johnson G. (1993). J. Biol. Chem., 268, 17896-17901.
22. Harris A, Nicholson S, Sainsbury J, Farndon J and Wright C (1989). J. Steroid Biochemistry, 34, 123-131.
23. Hazan R, Margolis B, Dombalagian M, Ullrich A, Zilberstein A and Schlessinger J. (1990). Cell Growth Diff., 1, 3-7.
24. Heldin C-H. (1996). Cell Signalling, Vol. 27: Cancer Surreys. Parker, P. and Pawson, T. (eds). Cold Spring Harbor Laboratory Press: New York, pp. 7-24.
25. Hu Q, Klippel A, Muslin AJ, Fantl W and Williams L. (1995). Science, 268, 100-102.
26. Hudziak R, Schlessinger J and Ullrich A. (1987). Proc. Natl. Acad. Sci. USA, 84, 7159-7163.
27. Janes P, Daly R, deFazio A and Sutherland R. (1994). Oncogene, 9, 3601-3608.
28. Jardines L, Weiss M, Fowble B and Greene M. (1993). Pathobiol., 61, 268-282.
29. Kallioniemi O-P, Kallioniemi A, Kurisu W, Thor A, Chen L-C, Smith H, Waldman F, Pinkel D and Gray J. (1992). Proc. Natl. Acad. Sci. USA, 89, 5321-5325.
30. Koenders P, Beex L, Kienhuis C, Kloppenborg P and Benraad T. (1992). Breast Cancer Res. Treat., 23, 134-145.
31. Li K, Shao R and Hung M-C. (1998). Proc. Am. Assoc. Cancer Res., 39, 1404.
32. Li N, Batzer A, Daly R, Yajnik V, Skolnik E, Chardin P, Bar-Sagi D, Margolis B and Schlessinger J. (1993). Nature, 363, 85-88.
33. Lowenstein E, Daly R, Batzer A, Li W, Margolis B, Lammers R, Ullrich A, Skolnik E, Bar-Sagi D and Schlessinger J. (1992). Cell, 70, 431-442.
34. Majeti R, Bilwes A, Noel J, Hunter T and Weiss A. (1998). Science, 279, 88-91.
35. Marais R and Marshall C. (1996). Cell Signalling, Vol. 27: Cancer Surveys. Parker, P. and Pawson, T. (eds). Cold Spring Harbor Laboratory Press: New York, pp. 101-125.
36. Margolis B, Lax R, Kris R, Dombalagian M, Honegger A, Howk R, Givol D, Ullrich A and Schlessinger J. (1989). J. Biol. Chem., 264, 10667-10671.
37. Nicholson S, Halcrow P, Sainsbury J, Angus B, Chanbers P, Farndon J and Harris A. (1988). Br. J. Cancer, 58, 810-814.
38. Pawson T. (1995). Nature, 373, 573-580.
39. Peles E, Lamprecht R, Ben-Levy R, Tzahar E and Yarden Y. (1992). J. Biol. Chem., 267, 12266-12274.
40. Pendergast A, Quilliam L, Cripe L, Bassing C, Dai Z, Li N, Batzer A, Rabun K, Der C, Schlessinger J and Gishizky M. (1993). Cell, 75, 175-185.
41. Pietras R, Arboleda J, Reese D, Wongvipat N, Pegram M, Ramos L, Gorman C, Parker M, Sliwkowski M and Slamon D. (1995). Oncogene, 10, 2345-2446.
42. Ram T and Ethier S. (1996). Cell Growth Diff., 7, 551-561.
43. Roche S, Koegl M and Courtneidge S. (1994). Proc. Nat. Acad. Sci. USA. 91, 9185-9189.
44. Rodriguez-Viciana P, Warne P, Dhand R, Vanhaesebroeck B, Gout I, Fry M, Waterfield M and Downward J. (1994). Nature, 370, 527-532.
45. Rodriguez-Viciana P, Warne P, Vanhaesebroeck B, Waterfield M and Downward J. (1996). EMBO J., 15, 2442-2451.
46. Rozakis-Adcock M, Fernley R, Wade J, Pawson T and Bowtell D (1993). Nature, 363, 83-85.
47. Schlessinger J and Ullrich A. (1992). Neuron, 9, 383-391.
48. Segatto O, Pelicci G, Giuli S, Digiese G, DiForc P, MeGlade J, Pawson T and Pelicci P. (1993). Oncogene, 8, 2105-2112.
49. Sepp-Lorenzino L, Eberhard I, Ma Z, Cho C, Serve H, Liu F, Rosen N and Lupu R. (1996). Oncogene, 128, 1679-1687.
50. Simon M, Bowtell D, Dodson G, Laverty T und Rubin G. (1991). Cell, 67, 701-716.
51. Simon M, Dodson G and Rubin G. (1993) Cell, 73, 169-177.
52. Skorski T, Kanakaraj P, Ku D-H, Nieborowska-Skorska M, Ratajczak M, Wen S-C, Zon G, Gewirtz A, Perussia B and Calabretta B. (1995). Blood, 86, 726-736.
53. Slamon D, Clark M, Wong S, Levin W, Ullrich A and McAuire W. (1987). Science, 235, 177-181.
54. Stern M, Marenger L, Daly R, Lowenstein E, Kokel M, Batzer A, Olivier P, Pawson T and Schlessinger J. (1993). Mol. Biol. Cell., 4, 1175-1188.
55. Suen K, Bustelo X, Pawson T and Barbacid M. (1993). Mol. Cell Biol., 13, 5500-5512.
56. Tan M, Yao J and Yu D. (1997). Cancer Res., 57, 1199-1205.
57. Tari A, Arlinghaus R and Lopez-Berestein G. (1997). Biochem. Biophys. Res. Comm., 235, 383-388.
58. Treisman R. (1996). Curr. Opin. Cell Biol., 8, 205-215.
59. Ullrich A and Schlessinger J. (1990) Cell, 61, 203-212.
60. Vanhaescbroeck B, Stein R and Waterfield M. (1996). Cell signalling, Vol. 27: Cancer Surveys. Parker, P. and Pawson, T. (eds). Cold Spring Harbor Laboratory Press: New York, pp. 249-270.
61. Velu T, Beguinot L, Vass W, Willingham M, Merlino G, Pastan I and Lowy D. (1987). Science, 238, 1408-1410.
62. Xie Y, Pendergast A and Hung M-C. (1995). J. Biol. Chem., 270, 30717-30724.
63. Yablonski D, Kuhne M, Kadlecek T and Weiss A. (1998). Science, 281, 413-416.
64. Yu D, Liu B, Tan M, Junzhi L, Wang S-S and Hung M-C. (1996). Oncogene, 13, 1359-1365.
65. Zhang L, Chang C, Bacus S and Hung M-C. (1995). Cancer Res., 55, 3890-3896.